Global Ventricular Assist Devices Market 2016-2020


#810420

93pages

Technavio

$ 2500

In Stock

About VADs

VADs are of three types - LVADs, BiVADs, and RVADs - that are used to treat heart failure. VADs help the weakened heart to pump blood for circulation to other body organs. Surgeons implant these mechanical devices as a treatment option for severe heart conditions such as acute or chronic cardiac functional deterioration and heart failure.

Technavios analysts forecast the global ventricular assist devices (VADs) market to grow at a CAGR of 12.04% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global ventricular assist devices (VADs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of different VADs. They are left ventricular assist devices, biventricular assist devices, and right ventricular assist devices.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Ventricular Assist Devices (VADs) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
ABIOMED
Berlin Heart
HeartWare
St. Jude Medical

Other prominent vendors
CardiacAssist Technologies
CORWAVE
EVAHEART
Jarvik Heart
Leviticus Cardio
ReliantHeart
Sunshine Heart
Ventracor

Market driver
Favorable reimbursement scenario
For a full, detailed list, view our report

Market challenge
Availability of alternative treatments
For a full, detailed list, view our report

Market trend
Focus on evidence-based research
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.






PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by product
Global LVADs market
Global BiVADs market
Global RVADs market
PART 07: Market segmentation by application
BTT therapy
BTD therapy
Destination therapy
BTR therapy
PART 08: Market segmentation by end-user
ASCs
Hospitals
Physicians' offices
PART 09: Geographical segmentation
VADs market in Americas
VADs market in EMEA
VADs market in APAC
PART 10: Market drivers
Shortage of heart donors and high cost of heart transplantation
Favorable reimbursement scenario
Outsourcing research studies on VADs to CROs
Focus on unmet needs for advanced heart failure
PART 11: Impact of drivers
PART 12: Market challenges
Availability of alternative treatments
Product recalls
Regulatory complications
Complications associated with VADs
PART 13: Impact of drivers and challenges
PART 14: Market trends
Advances in technology
Market strategies used by small companies for market penetration
Increase in M&A
Focus on evidence-based research
PART 15: Vendor landscape
Competitive scenario
Market share analysis 2015
PART 16: Major vendors
ABIOMED
Berlin Heart
HeartWare
St. Jude Medical
Other prominent vendors
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Worldwide prevalence of heart failure 2015
Exhibit 03: VADs: Technological developments
Exhibit 04: Global VADs market
Exhibit 05: Market scenario of LVADs, BiVADs, and RVADs
Exhibit 06: LVADs: Significant clinical outcomes
Exhibit 07: Global VADs market 2015-2020 ($ billions)
Exhibit 08: Five forces analysis
Exhibit 09: Global VADs market segmentation by product 2015
Exhibit 10: Global VADs market segmentation by product 2020
Exhibit 11: Global LVADs market: An overview
Exhibit 12: Global LVADs market 2015-2020 ($ billions)
Exhibit 13: Global LVADs market: Metrics analysis
Exhibit 14: Global BiVADs market: An overview
Exhibit 15: Global BiVADs market 2015-2020 ($ millions)
Exhibit 16: Global BiVADs market: Metrics analysis
Exhibit 17: Global RVADs market: An overview
Exhibit 18: Global RVADs market 2015-2020 ($ millions)
Exhibit 19: Global RVADs market: Metrics analysis
Exhibit 20: Global VAD market segmentation by application 2015
Exhibit 21: Overview of BTT therapy involving VADs
Exhibit 22: Overview of BTD therapy involving VADs
Exhibit 23: Overview of destination therapy involving VADs
Exhibit 24: Overview of BTR therapy involving VADs
Exhibit 25: Global VAD market segmentation by end-user 2015
Exhibit 26: Global VADs market segmentation by geography 2015 and 2020
Exhibit 27: Global VADs market segmentation by geography 2015-2020
Exhibit 28: Global VADs market segmentation by geography 2015-2020 ($ millions)
Exhibit 29: VADs market in Americas: An overview
Exhibit 30: Hospital admission for congestive heart failure per 100,000 individuals in some countries in Americas 2008 and 2013
Exhibit 31: VADs market in Americas 2015-2020 ($ millions)
Exhibit 32: VADs market in Americas: Metrics analysis for various countries
Exhibit 33: VADs market in US: PEST analysis
Exhibit 34: Implements amended in ACA in US
Exhibit 35: Impact of ACO and ACA on VADs
Exhibit 36: VADs market in EMEA: An overview
Exhibit 37: Hospital admission for congestive heart failure per 100,000 individuals in few countries in EMEA 2008 and 2013
Exhibit 38: VADs market in EMEA 2015-2020 ($ millions)
Exhibit 39: VADs market in EMEA: Metrics analysis for various countries
Exhibit 40: VADs market in UK: PEST analysis
Exhibit 41: VAD market in APAC
Exhibit 42: Hospital admission for congestive heart failure per 100,000 individuals in few countries in APAC 2008 and 2013
Exhibit 43: VADs market in APAC 2015-2020 ($ millions)
Exhibit 44: VADs market in APAC: Metrics analysis for various countries
Exhibit 45: VADs market in Japan: PEST analysis
Exhibit 46: Estimated number of people in various countries awaiting heart transplantation 2014
Exhibit 47: Estimated reimbursement cost in various countries
Exhibit 48: CROs that helped companies receive regulatory approval for VADs
Exhibit 49: Impact of drivers
Exhibit 50: Product recalls: VADs
Exhibit 51: VADs under investigational use
Exhibit 52: Impact of drivers and challenges
Exhibit 53: Advanced products and their market impact
Exhibit 54: Market strategies and their impact
Exhibit 55: Acquisitions by some companies
Exhibit 56: Global VADs market: Competitive landscape analysis 2015
Exhibit 57: Global VADs market share analysis 2015
Exhibit 58: ABIOMED: Metrics analysis
Exhibit 59: Berlin Heart: Metrics analysis
Exhibit 60: HeartWare: Metrics analysis
Exhibit 61: St. Jude Medical: Metrics analysis
Exhibit 62: Other prominent vendors